These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7713570)

  • 21. Effect of vaccines in a murine model of dormant tuberculosis.
    Dhillon J; Mitchison DA
    Tuber Lung Dis; 1994 Feb; 75(1):61-4. PubMed ID: 8161768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis.
    Dlugovitzky D; Fiorenza G; Farroni M; Bogue C; Stanford C; Stanford J
    Respir Med; 2006 Jun; 100(6):1079-87. PubMed ID: 16278080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease.
    Corlan E; Marica C; Macavei C; Stanford JL; Stanford CA
    Respir Med; 1997 Jan; 91(1):13-9. PubMed ID: 9068812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunotherapeutic efficacy of BCG vaccine in pulmonary tuberculosis and its preventive effect on multidrug-resistant tuberculosis].
    Lei JP; Xiong GL; Hu QF; Li Y; Zong PL; Tu SH; Tu RY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Feb; 42(2):86-9. PubMed ID: 18642658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic evaluation of mycobacterium vaccae in relation to Mycobacterium leprae.
    Navalkar RG; Chaparas SD; Lakshiminarayana CK; Kanchana MV
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):388-96. PubMed ID: 6782031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TB.
    Dlugovitzky D; Stanford C; Stanford J
    Immunotherapy; 2011 Apr; 3(4):557-68. PubMed ID: 21463195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis: current issues in diagnosis and treatment.
    Polkey MI; Rees PJ
    Br J Clin Pract; 1994; 48(5):251-5. PubMed ID: 7917820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Kamya RM; Okwera A; Loughlin AM; Nyole S; Hom DL; Wallis RS; Hirsch CS; Wolski K; Foulds J; Mugerwa RD; Ellner JJ
    J Infect Dis; 2000 Apr; 181(4):1304-12. PubMed ID: 10753731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pericarditis due to multidrug resistant Mycobacterium tuberculosis in an HIV infected patient: case report and review of literature].
    Lasso B M; Pérez G J
    Rev Chilena Infectol; 2009 Apr; 26(2):156-61. PubMed ID: 19621148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological changes with combined chemotherapy and immunotherapy in highly bacillated lepromatous leprosy.
    Natarajan M; Katoch K; Bagga AK; Katoch VM
    Acta Leprol; 1992; 8(2):79-86. PubMed ID: 1293915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species-specific antigenic Mycobacterium tuberculosis proteins tested by delayed-type hypersensitivity response.
    Hanif SN; Al-Attiyah R; Mustafa AS
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):489-94. PubMed ID: 20202308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunct immunotherapies for tuberculosis.
    Uhlin M; Andersson J; Zumla A; Maeurer M
    J Infect Dis; 2012 May; 205 Suppl 2():S325-34. PubMed ID: 22457298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
    Wang W; Jin G; Ye Y; Xia X; Wang A; Zhuang Y; Li G; Sun H; Wang Z; Lin M; Chen H; Li J; Dan Z; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):108-10. PubMed ID: 11820954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed disease.
    Corlan E; Marica C; Macavei C; Stanford JL; Stanford CA
    Respir Med; 1997 Jan; 91(1):21-9. PubMed ID: 9068813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fight against tuberculosis.
    Scheindlin S
    Mol Interv; 2006 Jun; 6(3):124-30. PubMed ID: 16809472
    [No Abstract]   [Full Text] [Related]  

  • 37. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de B; Garner P
    Cochrane Database Syst Rev; 2001; (1):CD001166. PubMed ID: 11279709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The history of tuberculosis.
    Daniel TM
    Respir Med; 2006 Nov; 100(11):1862-70. PubMed ID: 16949809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunotherapy for MDR-TB (multi-drug resistant tuberculosis)--its feasibility].
    Tsuyuguchi I
    Kekkaku; 1999 Jun; 74(6):479-91. PubMed ID: 10423959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combating consumption.
    Brower V
    Nat Biotechnol; 1996 Sep; 14(9):1097-9. PubMed ID: 9631058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.